Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Obese women with PCOS are more likely to have fatty liver disease.

Loestrin effectively normalizes testosterone levels and improves PCOS symptoms with minimal side effects.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Women with high androgen levels may have more severe COVID-19 symptoms.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.